Comparison of the effects of nebivolol and valsartan on BP reduction and sleep apnoea activity in patients with essential hypertension and OSA

References

• Wieber SJ. The cardiac consequences of the obstructive sleep apnea-hypopnea syndrome. Mt Sinai J Med 2005;72:10-12
   PubMed Web of Science ®Google Scholar
• Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5
   PubMed Web of Science ®Google Scholar
• Bloch KE. Alternatives to CPAP in the treatment of the obstructive sleep apnea syndrome. Swiss Med Wkly 2006;136:261-7
   PubMed Web of Science ®Google Scholar
• Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med 2005;142:187-97
   PubMed Web of Science ®Google Scholar
• Pankow W, Nabe B, Lies A, et al. Influence of sleep apnea on 24-hour blood pressure. Chest 1997;112:1253-8
   PubMed Web of Science ®Google Scholar
• Ringler J, Basner RC, Shannon R, et al. Hypoxemia alone does not explain blood pressure elevations after obstructive apneas. J Appl Physiol 1990;69:2143-8
   PubMed Web of Science ®Google Scholar
• Lavie P, Hoffstein V. Sleep apnea syndrome: a possible contributing factor to resistant hypertension. Sleep 2001;24:721-5
   PubMed Web of Science ®Google Scholar
• Pelttari LH, Hietanen EK, Salo TT, et al. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing. Am J Hypertens 1998;11:272-9
   PubMed Web of Science ®Google Scholar
• Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84
   PubMed Web of Science ®Google Scholar
• Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73
   PubMed Web of Science ®Google Scholar
• Boudoulas H, Schmidt H, Geleris P, et al. Case reports on deterioration of sleep apnea during therapy with propranolol – preliminary studies. Res Commun Chem Pathol Pharmacol 1983;39:3-10
   PubMedGoogle Scholar
• Kraiczi H, Hedner J, Peker Y, et al. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000;161:1423-8
   PubMed Web of Science ®Google Scholar
• Mayer J, Weichler U, Herres-Mayer B, et al. Influence of metoprolol and cilazapril on blood pressure and on sleep apnea activity. J Cardiovasc Pharmacol 1990;16:952-61
   PubMed Web of Science ®Google Scholar
• Planes C, Foucher A, Leroy M, et al. Effect of celiprolol treatment in hypertensive patients with sleep apnea. Sleep 1999;22:507-13
   PubMed Web of Science ®Google Scholar
• McNeely W, Goa KL. Nebivolol in the management of essential hypertension: a review. Drugs 1999;57:633-51
   PubMed Web of Science ®Google Scholar
• Veverka A, Nuzum DS, Jolly JL. Nebivolol: a third-generation beta-adrenergic blocker. Ann Pharmacother 2006;40:1353-60
   PubMed Web of Science ®Google Scholar
• Ip MS, Lam B, Chan LY, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000;162:2166-71
   PubMed Web of Science ®Google Scholar
• Schulz R, Schmidt D, Blum A, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000;55:1046-51
   PubMed Web of Science ®Google Scholar
• Taddei S, Virdis A, Ghiadoni L, et al. Endothelial dysfunction in hypertension. J Cardiovasc Pharmacol 2001;38(Suppl. 2):S11-14
   PubMed Web of Science ®Google Scholar
• Danchin N, Genton P, Atlas P, et al. Comparative effects of atenolol and clonidine on polygraphically recorded sleep in hypertensive men: a randomized, double-blind, crossover study. Int J Clin Pharmacol Ther 1995;33:52-5
   PubMed Web of Science ®Google Scholar
• Rechtschaffen A, Kales A. A Manual of Standardized Terminology: Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles: UCLA Brain Information Service/Brain Research Institute, 1968
   Google Scholar
• Practice parameters for the indications for polysomnography and related procedures. Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee. Sleep 1997;20:406-22
   PubMedGoogle Scholar
• Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5
   PubMed Web of Science ®Google Scholar
• Black HR, Graff A, Shute D, et al. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril. J Hum Hypertens 1997;11:483-9
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects. Chronobiol Int 2005;22:755-76
   PubMed Web of Science ®Google Scholar
• Fietze I, Quispe-Bravo S, Hansch T, et al. Arousals and sleep stages in patients with obstructive sleep apnoea syndrome: changes under nCPAP treatment. J Sleep Res 1997;6:128-33
   PubMed Web of Science ®Google Scholar
• Weichler U, Herres-Mayer B, Mayer J, et al. Influence of antihypertensive drug therapy on sleep pattern and sleep apnea activity. Cardiology 1991;78:124-30
   PubMed Web of Science ®Google Scholar
• Kantola I, Rauhala E, Erkinjuntti M, et al. Sleep disturbances in hypertension: a double-blind study between isradipine and metoprolol. J Cardiovasc Pharmacol 1991;18(Suppl. 3):S41-5
   Google Scholar
• Yilmaz MB, Erdem A, Yalta K, et al. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol. Adv Ther 2008;25:871-83
   PubMed Web of Science ®Google Scholar
• Brismar K, Hylander B, Eliasson K, et al. Melatonin secretion related to side-effects of beta-blockers from the central nervous system. Acta Med Scand 1988;223:525-30
   PubMed Web of Science ®Google Scholar
• Stoschitzky K, Stoschitzky G, Brussee H, et al. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol. Cardiology 2006;106:199-206
   PubMed Web of Science ®Google Scholar
• Tamura A, Kawano Y, Naono S, et al. Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest 2007;131:130-5
   PubMed Web of Science ®Google Scholar
• Holwerda NJ, Fogari R, Angeli P, et al. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril. J Hypertens 1996;14:1147-51
   PubMed Web of Science ®Google Scholar
• Van NL, Schelling A, Vertommen C, et al. Nebivolol vs enalapril in the treatment of essential hypertension: a double-blind randomised trial. J Hum Hypertens 1997;11:813-19
   PubMed Web of Science ®Google Scholar
• Loredo JS, ncoli-Israel S, Dimsdale JE. Sleep quality and blood pressure dipping in obstructive sleep apnea. Am J Hypertens 2001;14:887-92
   PubMed Web of Science ®Google Scholar
• Stradling JR, Barbour C, Glennon J, et al. Which aspects of breathing during sleep influence the overnight fall of blood pressure in a community population? Thorax 2000;55:393-8
   PubMed Web of Science ®Google Scholar
• Lacourciere Y, Lefebvre J, Poirier L, et al. A double-blind crossover comparison of nebivolol and lisinopril in the treatment of ambulatory hypertension. Am J Ther 1994;1:74-80
   PubMedGoogle Scholar
• Chediak AD, cevedo-Crespo JC, Seiden DJ, et al. Nightly variability in the indices of sleep-disordered breathing in men being evaluated for impotence with consecutive night polysomnograms. Sleep 1996;19:589-92
   PubMed Web of Science ®Google Scholar
• Le BO, Hoffmann G, Tecco J, et al. Mild to moderate sleep respiratory events: one negative night may not be enough. Chest 2000;118:353-9
   PubMed Web of Science ®Google Scholar